Anika Therapeutics Inc Quick Ratio (ANIK) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Anika Therapeutics Inc   (NASDAQ: ANIK)

Anika Therapeutics Inc 's Quick Ratio

ANIK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.73 below Anika Therapeutics Inc average.

Within Medical Equipment & Supplies industry 86 other companies have achieved higher Quick Ratio than Anika Therapeutics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 158 to 1349.

Explain Quick Ratio?
How much Cash & cash equivalents ANIK´s has?
What are ANIK´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANIK Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 37.72 % 17.12 % -6 % -25.12 % -38.44 %
Y / Y Cash & cash equivalent Change -50.19 % -11.37 % 2.46 % -11.63 % -20.16 %
Quick Ratio MRQ 1.73 3.19 3.71 4.2 4.8
ANIK's Total Ranking # 1349 # 158 # 564 # 577 # 268
Seq. Current Liabilities Change 5.63 % -4.3 % 14.77 % 18.71 % -10.17 %
Seq. Cash & cash equivalent Change -42.49 % -17.72 % 1.24 % 3.96 % 2.34 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 87
Healthcare Sector # 524
Overall Market # 1349


Quick Ratio Statistics
High Average Low
18.24 7.26 1.45
(Mar 31 2015)   (Dec 31 2010)




Financial Statements
Anika Therapeutics Inc 's Current Liabilities $ 22 Millions Visit ANIK's Balance sheet
Anika Therapeutics Inc 's Cash & cash equivalent $ 38 Millions Visit ANIK's Balance sheet
Source of ANIK's Sales Visit ANIK's Sales by Geography


Cumulative Anika Therapeutics Inc 's Quick Ratio

ANIK's Quick Ratio for the trailling 12 Months

ANIK Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 1.61 % -15.92 % -27.47 % -18.92 % -14.45 %
Y / Y Cash & cash equivalent TTM Growth -17.33 % -10.72 % -14.55 % -18.6 % -18.93 %
Quick Ratio TTM 3.17 3.91 4.19 4.08 3.89
Total Ranking TTM # 3716 # 934 # 2389 # 2749 # 2881
Seq. Current Liabilities TTM Growth 7.77 % 4.09 % -1.83 % -7.74 % -10.82 %
Seq. Cash & cash equivalent TTM Growth -12.68 % -2.73 % 0.62 % -3.27 % -5.7 %

Quick ratio ranking by company, industry and sector >> Back to ANIK Financial Strength Comparisons >> Go to Compare ANIK Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $22.15 millions, cumulative Quick Ratio decreased to 3.17 below the Anika Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Anika Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 934 to 3716.

Explain Quick Ratio?
How much Cash & cash equivalents ANIK´s has?
What are ANIK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 194
Healthcare Sector # 867
Within the Market # 3716


trailing twelve months Quick Ratio Statistics
High Average Low
16.34 8.06 2.47
(Jun 30 2015)   (Sep 30 2021)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions

Date modified: 2026-09-08T16:32:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.